CALCULATE FLOW RATES IN DROPS PER MINUTES: Order: Zosyn 1.3 g in 100 mL D5W IVPB 98h to infuse over 30 min. Drop factor: 60 gtt/mL. Determine rate in gtt/min.

A) Patients with hypertension
Low molecular weight heparin (LMWH) is not primarily used to treat hypertension. Hypertension (high blood pressure) is typically managed with antihypertensive medications like ACE inhibitors, beta-blockers, diuretics, or calcium channel blockers. LMWH is an anticoagulant, which works to prevent blood clots rather than controlling blood pressure.

B) Patients with asthma
LMWH is not typically used to treat asthma. Asthma is a chronic respiratory condition that is usually managed with bronchodilators (e.g., albuterol) and anti-inflammatory drugs such as corticosteroids. While patients with asthma may be at risk for blood clots under certain conditions (e.g., severe asthma exacerbations, immobility), LMWH is not a first-line treatment for asthma.

C) Patients with diabetes
While people with diabetes may be at an increased risk of developing blood clots, LMWH is not specifically used to treat diabetes. Diabetes is typically managed with insulin, oral hypoglycemic agents, lifestyle modifications, and other medications to control blood glucose levels. LMWH is an anticoagulant used for conditions that require prevention of clot formation, such as deep vein thrombosis (DVT).

D) Patients with deep vein thrombosis (DVT)
LMWH is commonly prescribed to patients with deep vein thrombosis (DVT). DVT occurs when a blood clot forms in a deep vein, usually in the legs. LMWH is a type of anticoagulant that prevents the formation of further clots by inhibiting factors involved in blood clotting. It is especially effective for patients with DVT or those at high risk for thromboembolic events, such as after surgery or during prolonged immobility. LMWH provides more predictable anticoagulation and requires less frequent monitoring than unfractionated heparin, making it ideal for outpatient management and in hospital settings.

A) Neutropenia
Neutropenia refers to an abnormally low level of neutrophils, a type of white blood cell. While certain medications, such as chemotherapy agents and some antipsychotic drugs, can cause neutropenia, atenolol (a beta-blocker) is not typically associated with this side effect. Atenolol primarily affects the cardiovascular system by reducing heart rate and blood pressure, and it is not known to cause significant changes in white blood cell counts.

B) Bradycardia
Bradycardia, or a slower-than-normal heart rate, is a well-known and common adverse effect of beta-blockers, including atenolol. Beta-blockers work by blocking beta-adrenergic receptors, which decreases the heart rate and the force of contraction, as well as lowering blood pressure. In some individuals, this can lead to excessively low heart rates, which could be dangerous if the heart rate drops too much. Bradycardia can lead to symptoms such as dizziness, fainting, or fatigue, and may require dose adjustments or discontinuation of the medication

C) Anemia
Anemia, which is a condition characterized by a low red blood cell count or low hemoglobin levels, is generally not a common adverse effect of atenolol. While certain medications like some chemotherapeutic agents, NSAIDs, or antibiotics may cause anemia due to their effects on the bone marrow or by causing gastrointestinal bleeding, atenolol is not typically linked to this side effect.

D) Hypokalemia
Hypokalemia (low potassium levels) is typically associated with the use of diuretics or other medications that cause the kidneys to excrete more potassium, such as some classes of antibiotics and corticosteroids. However, atenolol, being a beta-blocker, does not directly affect potassium levels.